IDEX Co. (NYSE:IEX) Shares Sold by Amundi

Amundi trimmed its position in shares of IDEX Co. (NYSE:IEXFree Report) by 38.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,012,896 shares of the industrial products company’s stock after selling 631,055 shares during the period. Amundi owned approximately 1.34% of IDEX worth $211,817,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in IEX. Principal Financial Group Inc. increased its holdings in IDEX by 3.0% during the 3rd quarter. Principal Financial Group Inc. now owns 95,836 shares of the industrial products company’s stock worth $20,557,000 after purchasing an additional 2,820 shares during the last quarter. Rovin Capital UT ADV acquired a new position in IDEX during the 3rd quarter worth $283,000. Verdence Capital Advisors LLC bought a new stake in shares of IDEX in the 3rd quarter worth about $344,000. Assetmark Inc. acquired a new stake in IDEX during the third quarter valued at approximately $39,000. Finally, Mesirow Financial Investment Management Inc. bought a new position in IDEX during the 3rd quarter worth approximately $201,000. Hedge funds and other institutional investors own 97.96% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on IEX shares. Stifel Nicolaus boosted their price target on IDEX from $244.00 to $256.00 and gave the company a “buy” rating in a report on Wednesday, December 11th. Citigroup dropped their target price on shares of IDEX from $269.00 to $267.00 and set a “buy” rating on the stock in a report on Monday, January 13th. Royal Bank of Canada decreased their price target on shares of IDEX from $256.00 to $245.00 and set an “outperform” rating for the company in a report on Thursday, February 6th. Finally, DA Davidson dropped their price objective on shares of IDEX from $225.00 to $215.00 and set a “neutral” rating on the stock in a research note on Wednesday, February 19th. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $241.71.

Read Our Latest Stock Analysis on IDEX

IDEX Trading Down 0.1 %

Shares of NYSE:IEX opened at $187.36 on Monday. IDEX Co. has a fifty-two week low of $183.24 and a fifty-two week high of $246.36. The company has a quick ratio of 1.85, a current ratio of 2.53 and a debt-to-equity ratio of 0.49. The company has a market cap of $14.20 billion, a PE ratio of 28.17, a P/E/G ratio of 1.98 and a beta of 0.99. The company’s 50-day moving average price is $205.18 and its 200 day moving average price is $211.36.

IDEX (NYSE:IEXGet Free Report) last issued its quarterly earnings data on Tuesday, February 4th. The industrial products company reported $2.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.03 by $0.01. IDEX had a return on equity of 16.08% and a net margin of 15.45%. Sell-side analysts anticipate that IDEX Co. will post 8.26 earnings per share for the current year.

IDEX Company Profile

(Free Report)

IDEX Corporation, together with its subsidiaries, provides applied solutions worldwide. The company operates through three segments: Fluid & Metering Technologies (FMT), Health & Science Technologies (HST), and Fire & Safety/Diversified Products (FSDP). The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, and other fluid-handling pump modules and systems, as well as flow monitoring and other services for the food, chemical, general industrial, water and wastewater, agricultural, and energy industries.

Further Reading

Institutional Ownership by Quarter for IDEX (NYSE:IEX)

Receive News & Ratings for IDEX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IDEX and related companies with MarketBeat.com's FREE daily email newsletter.